M. Ohkoshi et al., EFFECTS OF SERINE-PROTEASE INHIBITOR FOY-305 AND HEPARIN ON THE GROWTH OF SQUAMOUS-CELL CARCINOMA, Anticancer research, 13(4), 1993, pp. 963-966
Effects of serine proteinase inhibitor FOY-305 and heparin on autochth
onous skin carcinoma were examined using ddY female mice with single t
umor induced by methylcholanthrene. FOY-305 given intraperitoneally fo
r 9 consecutive weeks inhibited the growth of the pre-existing dermal
tumors. Heparin alone was equally therapeutically effective. However,
heparin induced severe mucocutaneous bleeding of the gastrointestinal
mucosa. In contrast, the combined administration of FOY-305 and hepari
n suppressed tumor growth without any visible side effects. There was
a significant increase in well differentiated cancer cells in mice tre
ated with FOY-305 and heparin in combination, suggesting that co-admin
istration of FOY-305 and heparin may be useful for the treatment of sq
uamous cell carcinoma.